Arena Pharmaceuticals, Inc. Deferred Revenue (Non-Current)
Arena Pharmaceuticals, Inc. had Deferred Revenue (Non-Current) of $415.00 thousand as of 2018-09-30, per its 10-Q filed 2018-11-08.
Discontinued › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredRevenueNoncurrent · last filed 2019-02-28
- 2018-09-30: Deferred Revenue, Noncurrent $415.00K.
- 2018-06-30: Deferred Revenue, Noncurrent $615.00K.
- 2018-03-31: Deferred Revenue, Noncurrent $815.00K.
- 2017-12-31: Deferred Revenue, Noncurrent $1.07M.
| Period end | Deferred Revenue, Noncurrent |
|---|---|
| 2018-09-30 | $415.00K 10-Q · filed 2018-11-08 |
| 2018-06-30 | $615.00K 10-Q · filed 2018-08-07 |
| 2018-03-31 | $815.00K 10-Q · filed 2018-05-09 |
| 2017-12-31 | $1.07M 10-K · filed 2019-02-28 |
| 2017-09-30 | $1.27M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $1.47M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $1.67M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $2.17M 10-K · filed 2018-03-14 |
| 2016-09-30 | $82.13M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $85.26M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $88.39M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $87.62M 10-K · filed 2017-03-15 |
| 2015-09-30 | $89.84M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $92.65M 10-Q · filed 2015-08-07 |
| 2015-03-31 | $91.03M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $93.06M 10-K · filed 2016-02-29 |
| 2014-09-30 | $95.09M 10-Q · filed 2014-11-06 |
| 2014-06-30 | $96.67M 10-Q · filed 2014-08-06 |
| 2014-03-31 | $99.22M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $101.33M 10-K · filed 2015-03-02 |
| 2013-09-30 | $46.39M 10-Q · filed 2013-11-12 |
| 2013-06-30 | $45.38M 10-Q · filed 2013-08-05 |
| 2013-03-31 | $46.33M 10-Q · filed 2013-05-09 |
| 2012-12-31 | $47.28M 10-K · filed 2014-03-03 |
| 2012-09-30 | $43.55M 10-Q · filed 2012-11-09 |
| 2012-06-30 | $44.06M 10-Q · filed 2012-08-09 |
| 2012-03-31 | $40.35M 10-Q · filed 2012-05-02 |
| 2011-12-31 | $41.21M 10-K · filed 2013-03-01 |
| 2011-09-30 | $41.35M 10-Q · filed 2011-11-09 |
| 2011-06-30 | $42.31M 10-Q · filed 2011-08-09 |
| 2010-12-31 | $44.23M 10-K · filed 2012-03-15 |